Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
| Revenue (TTM) | $20.07B |
| Gross Profit (TTM) | $13.81B |
| EBITDA | $5.34B |
| Operating Margin | 19.70% |
| Return on Equity | 12.40% |
| Return on Assets | 5.98% |
| Revenue/Share (TTM) | $13.56 |
| Book Value | $16.34 |
| Price-to-Book | 4.28 |
| Price-to-Sales (TTM) | 5.17 |
| EV/Revenue | 5.64 |
| EV/EBITDA | 22.18 |
| Quarterly Earnings Growth (YoY) | 18.50% |
| Quarterly Revenue Growth (YoY) | 15.90% |
| Shares Outstanding | $1.49B |
| Float | $1.48B |
| % Insiders | 0.21% |
| % Institutions | 95.05% |
Volatility is currently contracting